147 related articles for article (PubMed ID: 37328007)
21. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
22. Infection microenvironment-activated core-shell nanoassemblies for photothermal/chemodynamic synergistic wound therapy and multimodal imaging.
Qi Y; Ren S; Ye J; Tian Y; Wang G; Zhang S; Du L; Li Y; Che Y; Ning G
Acta Biomater; 2022 Apr; 143():445-458. PubMed ID: 35235864
[TBL] [Abstract][Full Text] [Related]
23. Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms.
Wang C; Dai C; Hu Z; Li H; Yu L; Lin H; Bai J; Chen Y
Nanoscale Horiz; 2019 Mar; 4(2):415-425. PubMed ID: 32254094
[TBL] [Abstract][Full Text] [Related]
24. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
[TBL] [Abstract][Full Text] [Related]
25. Multi-stimuli responsive mesoporous silica-coated carbon nanoparticles for chemo-photothermal therapy of tumor.
Lu H; Zhao Q; Wang X; Mao Y; Chen C; Gao Y; Sun C; Wang S
Colloids Surf B Biointerfaces; 2020 Jun; 190():110941. PubMed ID: 32169778
[TBL] [Abstract][Full Text] [Related]
26. A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy.
Wang D; Zhang N; Jing X; Zhang Y; Xu Y; Meng L
J Mater Chem B; 2020 Sep; 8(36):8271-8281. PubMed ID: 32812996
[TBL] [Abstract][Full Text] [Related]
27. Improvement of Photostability and NIR Activity of Cyanine Dye through Nanohybrid Formation: Key Information from Ultrafast Dynamical Studies.
Bera A; Bagchi D; Pal SK
J Phys Chem A; 2019 Sep; 123(35):7550-7557. PubMed ID: 31402654
[TBL] [Abstract][Full Text] [Related]
28. High-Performance Near-Infrared Aggregation-Induced Emission Luminogen with Mitophagy Regulating Capability for Multimodal Cancer Theranostics.
Li Y; Zhuang J; Lu Y; Li N; Gu M; Xia J; Zhao N; Tang BZ
ACS Nano; 2021 Dec; 15(12):20453-20465. PubMed ID: 34843216
[TBL] [Abstract][Full Text] [Related]
29. Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.
Kumeria T; McInnes SJP; Maher S; Santos A
Expert Opin Drug Deliv; 2017 Dec; 14(12):1407-1422. PubMed ID: 28398108
[TBL] [Abstract][Full Text] [Related]
30. An NIR-II-Emissive Photosensitizer for Hypoxia-Tolerant Photodynamic Theranostics.
Li L; Shao C; Liu T; Chao Z; Chen H; Xiao F; He H; Wei Z; Zhu Y; Wang H; Zhang X; Wen Y; Yang B; He F; Tian L
Adv Mater; 2020 Nov; 32(45):e2003471. PubMed ID: 33029855
[TBL] [Abstract][Full Text] [Related]
31. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
[TBL] [Abstract][Full Text] [Related]
32. A multifunctional targeted nanoprobe with high NIR-II PAI/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
[TBL] [Abstract][Full Text] [Related]
33. Self-assembled heptamethine cyanine dye dimer as a novel theranostic drug delivery carrier for effective image-guided chemo-photothermal cancer therapy.
Jeong C; Uthaman S; Bagheri B; Kim J; Pillarisetti S; Park IK; Kim YC
J Control Release; 2021 Jan; 329():50-62. PubMed ID: 33259849
[TBL] [Abstract][Full Text] [Related]
34. Activatable Semiconducting Theranostics: Simultaneous Generation and Ratiometric Photoacoustic Imaging of Reactive Oxygen Species In Vivo.
Yang Z; Dai Y; Yin C; Fan Q; Zhang W; Song J; Yu G; Tang W; Fan W; Yung BC; Li J; Li X; Li X; Tang Y; Huang W; Song J; Chen X
Adv Mater; 2018 Jun; 30(23):e1707509. PubMed ID: 29707841
[TBL] [Abstract][Full Text] [Related]
35. A "Dual-Source, Dual-Activation" Strategy for an NIR-II Window Theranostic Nanosystem Enabling Optimal Photothermal-Ion Combination Therapy.
Zheng Z; Duan A; Dai R; Li Y; Chen X; Qin Y; Ren S; Li R; Cheng Z; Zhang R
Small; 2022 Jul; 18(27):e2201179. PubMed ID: 35665998
[TBL] [Abstract][Full Text] [Related]
36. Triple Hit with Drug Carriers: pH- and Temperature-Responsive Theranostics for Multimodal Chemo- and Photothermal Therapy and Diagnostic Applications.
Baek S; Singh RK; Kim TH; Seo JW; Shin US; Chrzanowski W; Kim HW
ACS Appl Mater Interfaces; 2016 Apr; 8(14):8967-79. PubMed ID: 26926826
[TBL] [Abstract][Full Text] [Related]
37. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
38. Theranostic Nanoprobes with Aggregation-Induced NIR-II Emission: from Molecular Design to Biomedical Application.
Jiang Y; Zhu L; Wu W
Chembiochem; 2023 Apr; 24(8):e202200777. PubMed ID: 36748168
[TBL] [Abstract][Full Text] [Related]
39. Polydopamine/IR820 nanoparticles as topical phototheranostics for inhibiting psoriasiform lesions through dual photothermal and photodynamic treatments.
Nirmal GR; Lin ZC; Lin CH; Sung CT; Liao CC; Fang JY
Biomater Sci; 2022 Oct; 10(21):6172-6189. PubMed ID: 36073349
[TBL] [Abstract][Full Text] [Related]
40. Gadolinium-Chelated Conjugated Polymer-Based Nanotheranostics for Photoacoustic/Magnetic Resonance/NIR-II Fluorescence Imaging-Guided Cancer Photothermal Therapy.
Hu X; Tang Y; Hu Y; Lu F; Lu X; Wang Y; Li J; Li Y; Ji Y; Wang W; Ye D; Fan Q; Huang W
Theranostics; 2019; 9(14):4168-4181. PubMed ID: 31281539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
